https://www.thebodypro.com/category/hiv-treatment-strategies/tag/id-week

The Latest

The Challenges of Assessing Guideline Adherence in a Rapidly Changing Treatment Landscape Img

The Challenges of Assessing Guideline Adherence in a Rapidly Changing Treatment Landscape

With more than 20 approved HIV antiretrovirals in the United States, physicians have many options for their patients -- they can choose one of the "preferred" drug regimens or deviate from treatment guidelines entirely.

Health Outcomes Worse for HIV-Positive Black Men Even Despite Equal Access Img

Health Outcomes Worse for HIV-Positive Black Men Even Despite Equal Access

A new study finds significant health disparities between black and white men with HIV, even though these men had equal access to health care through the Veterans Administration (VA).

Women and HIV: Same Treatment, Different Care Img

Women and HIV: Same Treatment, Different Care

Women with HIV should receive not only the same antiretroviral therapy as men, but also clinical care tailored to their specific risk factors and health care goals, according to Kathleen Squires, M.D.

Researchers Discuss Questions Surrounding HIV Treatment, Prevention Img

Researchers Discuss Questions Surrounding HIV Treatment, Prevention

Researchers at IDWeek 2015 discussed the logistics of delivering antiretroviral therapy to all 37 million people living with HIV in the world and how to reach people during acute HIV infection.

Promo Image

What's Hot in HIV Clinical Science

What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.

Promo Image

What 2014 Development Has the Biggest Impact on HIV Care?

Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …

Promo Image

HIV Drug Development Pipeline Update, Fall 2014 Edition

HIV treatment remains far from perfect, and there are still seats at the table available for improved antiretrovirals. Paul Sax, M.D., provides an update on several of the most noteworthy candidates currently in development.

Promo Image

What's Hot in HIV Treatment

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.

Racial Differences Seen in Comparison of Stribild and Atripla as First-Line Therapy Img

Racial Differences Seen in Comparison of Stribild and Atripla as First-Line Therapy

A new study finds that black people are less likely to keep their viral load down on Atripla -- and that more trouble with side effects may be the reason.

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It? Img

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

A single drug dose, taken no more than once a month, to treat HIV: It's no longer the stuff of idle fantasy. But in a world stuffed with excellent once-a-day drugs, will long-acting meds have value?